Literature DB >> 7489399

Unrestricted cell cycling and cancer.

M Strauss1, J Lukas, J Bartek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489399     DOI: 10.1038/nm1295-1245

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  30 in total

1.  Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists.

Authors:  Y N Chen; S K Sharma; T M Ramsey; L Jiang; M S Martin; K Baker; P D Adams; K W Bair; W G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion.

Authors:  Yirong Li; Martin Ligr; James P McCarron; Garrett Daniels; David Zhang; Xin Zhao; Fei Ye; Jinhua Wang; Xiaomei Liu; Iman Osman; Simon K Mencher; Hebert Lepor; Long G Wang; Anna Ferrari; Peng Lee
Journal:  Clin Cancer Res       Date:  2011-05-23       Impact factor: 12.531

3.  Molecular characterization of head and neck cancer: how close to personalized targeted therapy?

Authors:  Maria J Worsham; Haythem Ali; Jadranka Dragovic; Vanessa P Schweitzer
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

4.  Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.

Authors:  W A Brown; S A Skinner; C Malcontenti-Wilson; D Vogiagis; P E O'Brien
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

5.  Melanoma: Molecular Pathogenesis and Therapeutic Management.

Authors:  Yuxin Liu; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2014

6.  Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.

Authors:  D K Biswas; A P Cruz; E Gansberger; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss.

Authors:  Yan Gao; Jacson Shen; Edwin Choy; Henry Mankin; Francis Hornicek; Zhenfeng Duan
Journal:  Cell Oncol (Dordr)       Date:  2017-02-27       Impact factor: 6.730

8.  Expression of cell cycle regulating factor mRNA in small cell lung cancer xenografts.

Authors:  M Krarup; H S Poulsen; M Spang-Thomsen
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

9.  Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma.

Authors:  Ambrosi Pertia; David Nikoleishvili; Omar Trsintsadze; Nino Gogokhia; Laurent Managadze; Archil Chkhotua
Journal:  Int Urol Nephrol       Date:  2008-08-05       Impact factor: 2.370

10.  Tracing cell fates in human colorectal tumors from somatic microsatellite mutations: evidence of adenomas with stem cell architecture.

Authors:  J L Tsao; J Zhang; R Salovaara; Z H Li; H J Järvinen; J P Mecklin; L A Aaltonen; D Shibata
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.